AGP Picks
View all

Technology Center Malta
Provided by AGP

Technology Center Malta: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Center Malta.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on August 20, 2026

Aduro beauftragt Saipem mit Ingenieurplanung und Beschaffung für erste HCT-Anlage ihrer Art („FOAK“) in Chemelot
2 hours ago

Aduro beauftragt Saipem mit Ingenieurplanung und Beschaffung für erste HCT-Anlage ihrer Art („FOAK“) in Chemelot

Indeterminate GlobeNewswire
Aduro elige a Saipem para que le preste apoyo en ingeniería y aprovisionamiento para la primera instalación de HCT de este tipo en Chemelot
2 hours ago

Aduro elige a Saipem para que le preste apoyo en ingeniería y aprovisionamiento para la primera instalación de HCT de este tipo en Chemelot

Indeterminate GlobeNewswire
Aduro choisit Saipem pour soutenir l’ingénierie et l’approvisionnement de son installation HCT pionnière à Chemelot
2 hours ago

Aduro choisit Saipem pour soutenir l’ingénierie et l’approvisionnement de son installation HCT pionnière à Chemelot

Indeterminate GlobeNewswire
Aduro seleziona Saipem per il supporto alle attività di ingegneria e approvvigionamento per la sua prima struttura HCT nel suo genere (FOAK) a Chemelot
2 hours ago

Aduro seleziona Saipem per il supporto alle attività di ingegneria e approvvigionamento per la sua prima struttura HCT nel suo genere (FOAK) a Chemelot

Indeterminate GlobeNewswire
Aduro kiest Saipem voor engineering- en inkoopondersteuning voor de eerste-in-zijn-soort (‘FOAK’) HCT-faciliteit op Chemelot
2 hours ago

Aduro kiest Saipem voor engineering- en inkoopondersteuning voor de eerste-in-zijn-soort (‘FOAK’) HCT-faciliteit op Chemelot

Indeterminate GlobeNewswire
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement
2 hours ago

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

Indeterminate GlobeNewswire
Edesa Biotech Announces Pricing of $25.0 Million Public Offering
3 hours ago

Edesa Biotech Announces Pricing of $25.0 Million Public Offering

Indeterminate GlobeNewswire
AI-powered Martech Firm Tec-Do Announces  Completion of New Financing Round
3 hours ago

AI-powered Martech Firm Tec-Do Announces  Completion of New Financing Round

Indeterminate GlobeNewswire
钛动科技宣布完成新一轮融资
3 hours ago

钛动科技宣布完成新一轮融资

Indeterminate GlobeNewswire
Crypto News Today: AlphaPepe Presale Announces Launch Reveal As Ethereum Price Prediction Targets $10,000
4 hours ago

Crypto News Today: AlphaPepe Presale Announces Launch Reveal As Ethereum Price Prediction Targets $10,000

Indeterminate GlobeNewswire
Noitom Robotics Releases HiPHI, One of the Largest High-Precision Human Motion Datasets Ever Made Public, at the World Robot Conference
4 hours ago

Noitom Robotics Releases HiPHI, One of the Largest High-Precision Human Motion Datasets Ever Made Public, at the World Robot Conference

Indeterminate GlobeNewswire
诺亦腾机器人于世界机器人大会发布 HiPHI：全球公开规模最大的高精度人体运动数据集之一
4 hours ago

诺亦腾机器人于世界机器人大会发布 HiPHI：全球公开规模最大的高精度人体运动数据集之一

Indeterminate GlobeNewswire
Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline
4 hours ago

Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Technology Center Malta

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.